Myeloma therapy: 25 years forward--immune modulation then and now.
Durie
Brian G M
BG
Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Hematology/Oncology; and Aptium Oncology, Los Angeles, CA, USA.
D004358:Drug Therapy / Q000639:trends; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology*
D007155:Immunologic Factors